Cranioencephalic functional lymphoid units in glioblastomaCelia Dobersalske, Björn Scheffler, Laurèl Rauschenbach et al.|Nature Medicine|2024Cited by 41
KDM5B predicts temozolomide-resistant subclones in glioblastomaVivien Ullrich, Björn Scheffler, Sarah Ertmer et al.|iScience|2023Cited by 4
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Björn Scheffler, Pia Berger et al.|Clinical Cancer Research|2022Cited by 4
Supplementary Figure S2 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Björn Scheffler, Vivien Ullrich et al.|Unknown|2023Cited by 0
Supplementary Tables S1-4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Björn Scheffler, Vivien Ullrich et al.|Unknown|2023Cited by 0